PureCDM

Executive Summary

PureCDM is an Australian private company specializing in clinical data management (CDM) and eClinical solutions for biotechnology and medical device trials. Founded in 2020 and based in Melbourne, the firm leverages over 25 years of cross-functional expertise to offer tailored data capture, integration, review, and analysis workflows. Their focus is on flexible, collaborative, and risk-aware data management, aiming to accelerate high-quality data generation without developing therapeutics themselves. As a service provider, PureCDM supports sponsors in navigating complex trial data requirements, positioning itself as a reliable partner for early-stage and mid-size trials. The company operates in a niche segment of the clinical research ecosystem, differentiating through customizable solutions rather than a one-size-fits-all platform. With no disclosed funding or valuation, PureCDM remains a small private entity, but its established expertise and focus on data integrity could attract partnerships or clients seeking specialized CDM support.

Upcoming Catalysts (preview)

• Q3 2026Strategic partnership with a mid-sized biotech for trial data management60% success
• Q4 2026Launch of a new eClinical software platform feature50% success
• Q1 2027Expansion into the Southeast Asian clinical trial market40% success